The role of Chlamydia trachomatis in prostatitis syndrome - Our experience in diagnosis and treatment

Acta Dermatovenerologica Croatica

Volumn 15, Issue 3, 2007, Pages 135-140

  Škerk, Višnja ^a   Krhen, Ivan ^b   Čajić, Vjeran ^a   Markovinović, Leo ^a   Puntarić, Alemka ^a   Roglić, Srdan ^a   Zekan, Šime ^a   Ljubin Sternak, Sunčanica ^c   Lepej, Snježana Židovec ^a   Vince, Adriana ^a  

^a Croatia   (Croatia)

^b UNIVERSITY OF ZAGREB   (Croatia)

^c CROATIAN NATIONAL INSTITUTE OF PUBLIC HEALTH   (Croatia)

Author keywords

Chlamydia trachomatis; Diagnosis; Prostatitis syndrome; Treatment

Indexed keywords

AZITHROMYCIN; CIPROFLOXACIN; CLARITHROMYCIN; DOXYCYCLINE; MONOCLONAL ANTIBODY;

ARTICLE; BACTERIUM CULTURE; CHLAMYDIA TRACHOMATIS; CHLAMYDIASIS; CHRONIC DISEASE; DNA HYBRIDIZATION; HUMAN; IMMUNOFLUORESCENCE TEST; IMMUNOHISTOCHEMISTRY; LEUKOCYTE COUNT; MICROSCOPY; PROSTATE SECRETION; PROSTATITIS; RNA HYBRIDIZATION; URINALYSIS;

CHLAMYDIA INFECTIONS; CHLAMYDIA TRACHOMATIS; CHRONIC DISEASE; HUMANS; MALE; PROSTATITIS; SYNDROME;

EID: 34948889668     PISSN: 1330027X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Naber KG, Weidner W. Prostatitis, epididymitis and orchitis. In: Cohen J, Powderly WG, eds. Infectious diseases. Edinburgh:Mosby; pp. 2004;745-50.
2. Meares EM, Stamey TA. Bacteriologic localization patterns in bacterial prostatitis and urethritis. Invest Urol 1968;5:492-518.
3. European Association of Urology. Guidelines on urinary and male genital tract infections. Arnhem, The Netherlands: Drukkerij Gelderland bV; 2002. pp.49-56.
4. Drach GW, Meares EM, Fair WR, Stamey TA. Classification of benign diseases associated with prostatic pain: prostatitis or prostatodynia? J Urol 1978;120:266.
5. Workshop Committee of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). Chronic Prostatitis Workshop, Bethesda, MD, 7-8 December, 1995.
6. McMillan A, Ballard RC. Non specific genital tract infection and chlamydial infection including lymphogranuloma venerum. In: McMillan A, Young H, Ogilvie MM, Scott GR, eds. Clinical practice in sexually transmissible infections. London, UK: Saunders; 2002. pp. 281-312.
7. Gomberg M. Persistent chlamydial infection. Medicus 2003;12:179-88.
8. Skerk V, Schonwald S, Granic J, Krhen I, Barsic B, Marekovic I, et al. Chronic prostatitis caused by Trichomonas vaginalis - diagnosis and treatment. J Chemother 2002;14:537-8.
9. Skerk V, Schonwald S, Krhen I, Strapac Z, Markovinovic L, Kruzic V, et al. Azithromycin in the treatment of chronic prostatitis caused by Chlamydia trachomatis. J Chemother 2001;13:664-5.
10. Skerk V, Schonwald S, Krhen I, Markovinovic L, Barsic B, Marekovic I, et al. Comparative analysis of azithromycin and clarithromycin efficacy and tolerability in the treatment of chronic prostatitis caused by Chlamydia trachomatis. J Chemother 2002;14:384-9.
11. Skerk V, Schonwald S, Krhen I, Banaszak A, Begovac J, Strugar J, et al. Comparative analysis of azithromycin and ciprofloxacin in the treatment of chronic prostatitis caused by Chlamydia trachomatis. Int J Antimicrob Agents 2003;21:457-62.
12. Skerk V, Krhen I, Lisic M, Begovac J, Cajic V, Zekan S, et al. Azithromycin: 4.5- or 6.0-gram dose in the treatment of patients with chronic prostatitis caused by Chlamydia trachomatis - a randomized study. J Chemother 2004;16:408-10.
13. Skerk V, Krhen I, Lisic M, Begovac J, Roglic S, Skerk V, et al. Comparative randomized pilot study of azithromycin and doxycycline efficacy and tolerability in the treatment of prostate infection caused by Chlamydia trachomatis. Int J Antimicrob Agents 2004;24:188-91.
14. Skerk V, Schonwald S, Krhen I, Markovinovic L, Beus A, Sterk-Kuzmanovic N, et al. Aetiology of chronic prostatitis. Int J Antimicrob Agents 2002;19:471-4.
15. Skerk V, Krhen I, Schonwald S, Cajic V, Markovinovic L, Roglic S, et al. The role of unusual pathogens in prostatitis syndrome. Int J Antimicrob Agents 2004;24(Suppl):S53-6.
16. Litwin MS, McNaughton-Collins M, Fowler FJ Jr, Nicke JC, Calhoun EA, Pontari MA, et al. The National Institutes of Health Chronic Prostatitis Symptom Index: development and validation of a new outcome measure. Chronic Prostatitis Collaborative Research Network. J Urol 1999;162:369-75.
17. Naber KG. Experience with the new guidelines on evaluation of new anti-infective drugs for the treatment of urinary tract infections. Int J Antimicrob Agents 1999;11:189-96.